Citi Raises Becton Dickinson (BDX) PT to $198 after Life Sciences Sale Update

Becton, Dickinson and Company (NYSE:BDX) is included among the 13 Cheapest Dividend Aristocrats to Invest in.

On February 11, Citi expert Joanne Wuensch lifted her terms proposal connected Becton, Dickinson and Company (NYSE:BDX) to $198 from $185.70 and maintained a Buy rating. The accommodation came aft the steadfast updated its fiscal exemplary to relationship for the merchantability of the Life Sciences business.

During the company’s fiscal Q1 2026 net call, CEO Thomas Polen introduced Shawn Bevec arsenic the caller Senior Vice President of Investor Relations. He said the twelvemonth had begun connected coagulated footing, with results coming successful up of expectations. In his view, show reflected disciplined execution, stronger commercialized momentum, and continued concern successful the company’s cardinal maturation platforms.

Revenue for the 4th reached $5.3 billion. That translated into 0.4% wide maturation and 2.5% maturation wrong the New BD segment. Polen noted that respective areas delivered double-digit growth, including biologic cause delivery, PureWick, precocious insubstantial regeneration, and pharmacy automation. Advanced Patient Monitoring posted precocious single-digit growth. Adjusted gross borderline roseate to 53.4%, portion adjusted EPS came successful astatine $2.91, some supra interior forecasts.

He besides said the institution expected to adjacent the operation of its Life Sciences portion with Waters Corporation done a Reverse Morris Trust transaction aboriginal that morning. The woody is acceptable to make a $4 cardinal currency distribution. Of that amount, $2 cardinal is planned for stock repurchases, with the remaining $2 cardinal directed toward indebtedness reduction. Polen described the determination arsenic aligned with BD’s much focused superior allocation strategy.

On the strategical front, helium pointed to the “Excellence Unleashed” agenda, which aims to sharpen competitiveness, velocity up innovation, and guarantee accordant execution. Early signs of advancement were already visible. The institution expanded its income unit and captured caller competitory wins. Alaris, for example, delivered its strongest 4th of competitory gains since its relaunch, expanding class stock by astir 100 ground points.

Becton, Dickinson and Company (NYSE:BDX) operates arsenic a planetary aesculapian exertion company, processing and selling aesculapian supplies, devices, laboratory equipment, and diagnostic products utilized by hospitals, physicians, beingness sciences researchers, and objective laboratories worldwide.

While we admit the imaginable of BDX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you’re looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.